{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:20:19Z","timestamp":1786123219181,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1213\/ane.0b013e31820b5f1f","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T08:12:40Z","timestamp":1299312760000},"page":"1115-1123","source":"Crossref","is-referenced-by-count":70,"title":["Complications Associated with the Administration of Dantrolene 1987 to 2006"],"prefix":"10.1213","volume":"112","author":[{"given":"Barbara W.","family":"Brandom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn Green","family":"Larach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Shue Alvin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-29-20210902","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/252728a0","article-title":"Effect of dantrolene sodium on calcium movements in single muscle fibers.","volume":"252","author":"Hainaut","year":"1974","journal-title":"Nature"},{"key":"R3-29-20210902","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00000542-198204000-00005","article-title":"Dantrolene in human malignant hyperthermiaa multicenter study.","volume":"56","author":"Kolb","year":"1982","journal-title":"Anesthesiology"},{"key":"R4-29-20210902","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","article-title":"Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.","volume":"110","author":"Larach","year":"2010","journal-title":"Anesth Analg"},{"key":"R5-29-20210902","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/ALN.0b013e318167aee2","article-title":"Cardiac arrests and deaths associated with malignant hyperthermia in North America from 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States.","volume":"108","author":"Larach","year":"2008","journal-title":"Anesthesiology"},{"key":"R6-29-20210902","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1185\/03007998409109576","article-title":"Long-term treatment with dantrolene sodium of stroke patients with spasticity limiting the return of function.","volume":"9","author":"Ketel","year":"1984","journal-title":"Curr Med Res Opin"},{"key":"R7-29-20210902","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12028-008-9133-4","article-title":"Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit.","volume":"10","author":"Muehlschlegel","year":"2009","journal-title":"Neurocrit Care"},{"key":"R8-29-20210902","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12028-008-9132-5","article-title":"Dantrolene mediates vasorelaxation in cerebral vasoconstriction: a case series.","volume":"10","author":"Musehlschlegel","year":"2009","journal-title":"Neurocrit Care"},{"key":"R9-29-20210902","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/archinte.1989.00390090009002","article-title":"Neuroleptic malignant syndrome. Review of response to therapy.","volume":"149","author":"Rosenberg","year":"1989","journal-title":"Arch Intern Med"},{"key":"R10-29-20210902","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S1481803500012598","article-title":"Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review.","volume":"12","author":"Grunau","year":"2010","journal-title":"CJEM"},{"key":"R11-29-20210902","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4065\/70.3.241","article-title":"Clinical effects of intravenously administered dantrolene.","volume":"70","author":"Wedel","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"R12-29-20210902","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00000542-197902000-00016","article-title":"Orally administered dantrolene for prophylaxis of malignant hyperthermia.","volume":"50","author":"Pandit","year":"1979","journal-title":"Anesthesiology"},{"key":"R13-29-20210902","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00000542-198609000-00012","article-title":"Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia.","volume":"65","author":"Watson","year":"1986","journal-title":"Anesthesiology"},{"key":"R14-29-20210902","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1399-6576.1987.tb02573.x","article-title":"Spinal block, after dantrolene pretreatment, for resection of a thigh muscle herniation in a young malignant hyperthermia susceptible man.","volume":"31","author":"Oikkonen","year":"1987","journal-title":"Acta Anaesthesiol Scand"},{"key":"R15-29-20210902","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/00000542-198812000-00016","article-title":"Plasma levels of dantrolene following oral administration in malignant hyperthermia-susceptible patients.","volume":"69","author":"Allen","year":"1988","journal-title":"Anesthesiology"},{"key":"R16-29-20210902","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF03010893","article-title":"Rewarming following hypothermic cardiopulmonary bypass in the malignant hyperthermia-susceptible patient: implications for diagnosis and perioperative management.","volume":"36","author":"Allen","year":"1989","journal-title":"Can J Anaesth"},{"key":"R17-29-20210902","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.sc.3101553","article-title":"Dantrolene and pleural effusion: case report and review of literature.","volume":"42","author":"Le-Quang","year":"2004","journal-title":"Spinal Cord"},{"key":"R18-29-20210902","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.40.9.1427","article-title":"Dantrolene sodium and hepatic injury.","volume":"40","author":"Chan","year":"1990","journal-title":"Neurology"},{"key":"R19-29-20210902","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00000542-198702000-00028","article-title":"Hyperkalemia, verapamil, and dantrolene.","volume":"66","author":"Rubin","year":"1987","journal-title":"Anesthesiology"},{"key":"R20-29-20210902","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0888-6296(88)90319-5","article-title":"Dantrolene-induced hyperkalemia in a patient treated with diltiazem and metoprolol.","volume":"2","author":"Yoganathan","year":"1988","journal-title":"J Cardiothorac Anesth"},{"key":"R21-29-20210902","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","article-title":"A clinical grading scale to predict malignant hyperthermia susceptibility.","volume":"80","author":"Larach","year":"1994","journal-title":"Anesthesiology"},{"key":"R22-29-20210902","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00000542-198310000-00002","article-title":"Dantrolene dose response in awake man: implications for management of malignant hyperthermia.","volume":"59","author":"Flewellen","year":"1983","journal-title":"Anesthesiology"},{"key":"R23-29-20210902","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/01.anes.0000265148.86566.68","article-title":"Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions.","volume":"106","author":"Burkman","year":"2007","journal-title":"Anesthesiology"},{"key":"R25-29-20210902","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/jsre.1997.5134","article-title":"Calcium release from intracellular stores and excitationcontraction coupling in intestinal smooth muscle.","volume":"71","author":"Oh","year":"1997","journal-title":"J Surg Res"},{"key":"R27-29-20210902","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00000542-198904000-00013","article-title":"Pharmacokinetics of intravenous dantrolene in children.","volume":"70","author":"Lerman","year":"1989","journal-title":"Anesthesiology"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0b013e31820b5f1f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:25:17Z","timestamp":1786112717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201105000-00029"}},"subtitle":["A Report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States"],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e31820b5f1f","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}